Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Solasia Pharma K.K. (Tokyo:4597) said Japan's Ministry of Health, Labour and Welfare (MHLW) approved Episil (SP-03)
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury